Tutorials
TSE:4575 (Japan)  
CanBas Co Ltd logo

CanBas Co Ltd

円 663.00 (+3.59%) Aug 5
P/E:
At Loss
P/B:
29.29
Market Cap:
円 7.09B ($ 52.53M)
Enterprise V:
円 6.77B ($ 50.16M)
Volume:
1.17M
Avg Vol (2M):
4.27M
Volume:
1.17M
Market Cap 円:
7.09B
Market Cap $:
52.53M
PE Ratio:
At Loss
Avg Vol (2-Month):
4.27M
Enterprise Value 円:
6.77B
Enterprise Value $:
50.16M
PB Ratio:
29.29
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Description
CanBas Co Ltd focuses on the discovery and development of novel oncology drugs targeting the cell cycle. Its product, CBP501 the anticancer drug candidate is a modified synthetic peptide which enhances the efficacy of cisplatin without adding toxicity.
Name Current Vs Industry Vs History
Cash-To-Debt 1.87
Equity-to-Asset 0.32
Debt-to-Equity 1.56
Debt-to-EBITDA -0.51
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -13
Distress
Grey
Safe
Beneish M-Score -4.25
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 28.9
9-Day RSI 37.28
14-Day RSI 44.77
6-1 Month Momentum % 157.08
12-1 Month Momentum % 73.62

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.11
Quick Ratio 5.11
Cash Ratio 4.97
Days Sales Outstanding 212.2

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -16.6

Financials

TSE:4575's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil 円) 26.133
EPS (TTM) (円) -80.53
Beta -0.41
Volatility % 268.8
14-Day RSI 44.77
14-Day ATR (円) 78.135794
20-Day SMA (円) 807.45
12-1 Month Momentum % 73.62
52-Week Range (円) 162 - 1054
Shares Outstanding (Mil) 10.7

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

CanBas Co Ltd Filings

Document Form Filing Date
No Filing Data